Published in J Neuropathol Exp Neurol on October 01, 1973
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77
Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci U S A (1985) 3.54
Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol (2009) 2.87
Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol (1988) 2.42
Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils. Acta Neuropathol (1992) 1.71
Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am J Pathol (2004) 1.70
Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet. Am J Pathol (2004) 1.66
Metabolism and possible health effects of aluminum. Environ Health Perspect (1986) 1.64
Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalon. Acta Neuropathol (1984) 1.60
Age-related pathology and biosenescent markers in captive rhesus macaques. Age (Omaha) (1997) 1.55
Reappraisal of the fine structure of Alzheimer's neurofibrillary tangles. Acta Neuropathol (1981) 1.48
Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease. Am J Pathol (1991) 1.43
Alzheimer's disease and the amyloid-beta peptide. J Alzheimers Dis (2010) 1.33
Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice. J Biol Chem (2007) 1.27
Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid. Am J Pathol (1992) 1.23
Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease. Proc Natl Acad Sci U S A (1994) 1.22
About the presence of paired helical filaments in dystrophic neurites participating in the plaque formation. Acta Neuropathol (1989) 1.18
Amyloid in the brains of aged squirrel monkeys. Acta Neuropathol (1990) 1.08
Nonhuman primate models of Alzheimer-like cerebral proteopathy. Curr Pharm Des (2012) 1.06
Differential brain expression of the Alzheimer's amyloid precursor protein. EMBO J (1989) 1.06
Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am J Pathol (1994) 1.05
Isolation and chemical characterization of Alzheimer's disease paired helical filament cytoskeletons: differentiation from amyloid plaque core protein. J Cell Biol (1988) 1.01
Rod-shaped filamentous inclusions and other ultrastructural features in a cerebellar astrocytoma. Acta Neuropathol (1975) 0.99
Recent rodent models for Alzheimer's disease: clinical implications and basic research. J Neural Transm (Vienna) (2011) 0.99
Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA. Am J Pathol (1989) 0.96
Brain aging in normotensive and hypertensive strains of rats. II. Ultrastructural changes in neurons and glia. Acta Neuropathol (1980) 0.91
Amyloid-beta peptide and oligomers in the brain and cerebrospinal fluid of aged canines. J Alzheimers Dis (2010) 0.89
Beta/A4 proteinlike immunoreactive granular structures in the brain of senescence-accelerated mouse. Am J Pathol (1993) 0.88
Studies on a murine form of spontaneous lower motor neuron degeneration--the wobbler (wa) mouse. Am J Pathol (1974) 0.84
Immunocytochemical and ultrastructural studies of the motor cortex in amyotrophic lateral sclerosis. Acta Neuropathol (1994) 0.82
Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis. Biochim Biophys Acta (2013) 0.81
Senile plaques in an aged two-humped (Bactrian) camel (Camelus bactrianus). Acta Neuropathol (1995) 0.80
Cerebral aging: a quantitative study of gliosis in old nude mice. Acta Neuropathol (1989) 0.80
Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity. Am J Pathol (1993) 0.79
C. elegans model of neuronal aging. Commun Integr Biol (2011) 0.77
Criteria for development of animal models of diseases of the nervous system. Am J Pathol (1980) 0.76
Needs for animal models of human diseases of the nervous system. Am J Pathol (1980) 0.76
Morphology and morphogenesis of cerebral ring hemorrhages in anemic monkeys. Acta Neuropathol (1980) 0.75
Ultrastructural study of Betz cells in the primary motor cortex of the human brain. J Anat (2001) 0.75
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A (1998) 6.13
Pathological verification of ischemic score in differentiation of dementias. Ann Neurol (1980) 5.25
Effects of mitotic spindle inhibitors on neurotubules and neurofilaments in anterior horn cells. J Cell Biol (1968) 4.65
Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet (1997) 4.11
Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol (1996) 4.10
A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science (1991) 4.09
Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch Pathol Lab Med (1993) 3.58
Fine structure and electrolyte analyses of cerebral edema induced by alkyl tin intoxication. J Neuropathol Exp Neurol (1963) 3.43
Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci (1987) 3.39
Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol (1981) 3.18
Neurofibrillary tangles of paired helical filaments. J Neurol Sci (1976) 2.80
Neurofibrillary pathology. J Neuropathol Exp Neurol (1970) 2.70
Senile dementia of the Alzheimer type. Ann Neurol (1983) 2.47
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (1999) 2.43
Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron (1998) 2.40
Experimental colchicine encephalopathy. I. Induction of neurofibrillary degeneration. Lab Invest (1967) 2.40
Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch Neurol (1973) 2.38
Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am J Pathol (1990) 2.24
Evidence that Alzheimer neurofibrillary tangles originate from neurotubules. Lancet (1979) 2.22
Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol (1992) 2.21
Neocortical cell counts in normal human adult aging. Ann Neurol (1987) 2.16
Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest (1992) 2.12
Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature (1980) 2.02
Immunocytochemical studies of neurofibrillary tangles. Am J Pathol (1981) 2.01
Presenilin-1 mutations in Alzheimer's disease. Nature (2000) 1.97
Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol (1998) 1.93
Senile plaques and cerebral amyloidosis in aged dogs. A histochemical and ultrastructural study. Lab Invest (1970) 1.93
Pick's disease. A clinical and ultrastructural study. Arch Neurol (1972) 1.89
Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci Lett (1989) 1.89
Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci U S A (1997) 1.89
Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J Neuropathol Exp Neurol (1974) 1.86
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci U S A (1994) 1.85
Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol (1988) 1.82
Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol (1998) 1.80
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol (1987) 1.78
Presenile dementia. Clinical aspects and evaluation of cerebrospinal fluid dynamics. Arch Neurol (1973) 1.77
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol (2004) 1.76
Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58. EMBO J (1991) 1.74
Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci U S A (1999) 1.73
Neurofibrillary changes in human brain. An immunocytochemical study with a neurofilament antiserum. J Neuropathol Exp Neurol (1983) 1.72
Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis. Ann Neurol (1977) 1.69
Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell (1994) 1.69
Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A (1993) 1.68
Landry-Guillain-Barré syndrome. A primary demyelinating disease. Arch Neurol (1969) 1.67
Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene. Nat Genet (1992) 1.66
Protein changes in senile dementia. Brain Res (1974) 1.65
Quantitative synaptic alterations in the human neocortex during normal aging. Neurology (1993) 1.61
Fine structural localization of acid phosphatase in senile plaques in Alzheimer's presenile dementia. Acta Neuropathol (1967) 1.58
Immunopathology of demyelination in autoimmune diseases and virus infections. Br Med Bull (1977) 1.52
Electron microscopic study in two cases of Jakob-Creutzfeldt disease. J Neuropathol Exp Neurol (1965) 1.51
Experimental hydrocephalus in young dogs: histological and ultrastructural study of the brain tissue damage. J Neuropathol Exp Neurol (1971) 1.50
Ultrastructural studies of multiple sclerosis. Lab Invest (1969) 1.49
Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol (1999) 1.49
Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol (1998) 1.48
The origin of the reactive cells in cerebral stab wounds. J Neuropathol Exp Neurol (1966) 1.45
Distribution of cholinergic neurons in rat brain: demonstrated by the immunocytochemical localization of choline acetyltransferase. J Comp Neurol (1983) 1.44
Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J Histochem Cytochem (1990) 1.43
The spatio-temporal pattern of Wallerian degeneration in mammalian peripheral nerves. Brain Res (1973) 1.41
Alzheimer's disease and spirochetes; a questionable relationship. Neuroreport (1993) 1.41
Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Nat Genet (1992) 1.41
Alzheimer neurofibrillary tangles: antiserum and immunohistological staining. Ann Neurol (1979) 1.39
Morphology of the aging brain, human and animal. Prog Brain Res (1973) 1.39
Tau pathology in a family with dementia and a P301L mutation in tau. J Neuropathol Exp Neurol (1999) 1.38
Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. Am J Pathol (1991) 1.37
A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V. J Biol Chem (2000) 1.34
Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Rev Neurol (Paris) (2013) 1.33
Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa. J Neuropathol Exp Neurol (1993) 1.33
Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc Natl Acad Sci U S A (2000) 1.31
Study on the propagation of Herpes simplex virus (type 2) into the brain after intraocular injection. Brain Res (1974) 1.31
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry (2013) 1.30
Reduced number and altered morphology of microglial cells in colony stimulating factor-1-deficient osteopetrotic op/op mice. Brain Res (1998) 1.29
Ultrastructure of thalamic neuronal inclusions in myotonic dystrophy. J Neurol Sci (1975) 1.26
Liposome toxicity in the mouse central nervous system. J Neurol Sci (1977) 1.26
A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol (1989) 1.23
Fibrous Astrocytes in senile dementia of the Alzheimer type. J Neuropathol Exp Neurol (1981) 1.23
Peripheral nerve ischemia. Part 1. Experimental model. J Neurol Sci (1975) 1.23
Infectious etiology of neuritic (senile) plaques in mice. Science (1975) 1.23
Dementia of the Alzheimer type. Annu Rev Neurosci (1980) 1.22
The role of oligodendroglia and astroglia in Wallerian degeneration of the optic nerve. Brain Res (1973) 1.22
Chemical relationship of the paired helical filaments of Alzheimer's dementia to normal human neurofilaments and neurotubules. Brain Res (1978) 1.21
Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease. Acta Neuropathol (1991) 1.20
Neuronal fibrous protein in human pathology. J Neuropathol Exp Neurol (1971) 1.20
On the association between microtubules and mitochondria within axons. Brain Res (1971) 1.18
Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse. Exp Brain Res (1995) 1.18
Studies on brain biopsies of patients with Huntington's chorea. J Neuropathol Exp Neurol (1974) 1.18
Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. J Neuropathol Exp Neurol (2001) 1.18
Vesicular disruption of myelin in autoimmune demyelination. J Neurol Sci (1975) 1.16
Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease. J Neuropathol Exp Neurol (1993) 1.14
Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol (2001) 1.14
Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch Neurol (1994) 1.14
Decreased levels of protein kinase C in Alzheimer brain. Brain Res (1988) 1.13
Neuropsychological function in nondemented carriers of presenilin-1 mutations. Neurology (2005) 1.13